(NASDAQ: PYPD) Polypid's forecast annual earnings growth rate of -86.99% is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 68.96%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.67%.
Polypid's earnings in 2026 is -$34,525,000.On average, 6 Wall Street analysts forecast PYPD's earnings for 2026 to be -$20,239,223, with the lowest PYPD earnings forecast at -$24,085,443, and the highest PYPD earnings forecast at -$11,341,416. On average, 4 Wall Street analysts forecast PYPD's earnings for 2027 to be -$15,009,179, with the lowest PYPD earnings forecast at -$18,102,435, and the highest PYPD earnings forecast at -$11,505,785.
In 2028, PYPD is forecast to generate $3,193,442 in earnings, with the lowest earnings forecast at $3,068,209 and the highest earnings forecast at $3,287,367.